The editors of JAMA recognize the challenges, concerns, and frustration about the shortage of personal protective equipment (PPE) that is affecting the care of
May 09, 2021
The Centers for Medicare & Medicaid Services (CMS) has come through with the anticipated new technology add-on payment (NTAP) for inpatient coronary intravascular lithotripsy (IVL) cases using the Shockwave IVL system and Shockwave C
2 coronary IVL catheter, clearing the way for additional reimbursement.
That would be welcome news for operators looking to offset the cost of the new technology recently approved by the US Food and Drug Administration for the treatment of severely calcified coronary plaques. At $4,700, the device cost is considerably higher than that of other calcium-modification tools on the market. With the NTAP, hospitals would receive a maximum of $3,666 for an inpatient procedure involving coronary IVL, although the exact amount will vary on a case-by-case basis.